City

Afula (1)

Iowa City (1)

Los Angeles (1)

Rochester (1)

Tampa (1)

Condition

Cardiomyopathy, Secondary (2)

Friedreich Ataxia (1)

Pneumonia (1)

Sepsis (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

HaEmek Medical Center, Israel (1)

Lexeo Therapeutics (1)

Collaborator

Intervention

ekocardiogram test (1)

high dose lx2006 (1)

low dose lx2006 (1)

Study Documents

Intervention Type

device (1)

genetic (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

cardiomyopathy, secondary

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Friedreich Ataxia, Cardiomyopathy, Secondary Trial in United States (Low dose LX2006, High Dose LX2006)

Recruiting

Friedreich Ataxia
Cardiomyopathy, Secondary

Low dose LX2006
High Dose LX2006

Los Angeles, California
+3 more

Dec 2, 2022

The Impact of Infectious Disease on QT Segment

Completed

Sepsis
+2 more

ekocardiogram test

Afula, Israel

Haemek Medical Center

Mar 13, 2018